North American Esoteric Testing Market revenue to cross $21 Bn by 2028

Published Date: 2022-10-31

Request a sample

North American Esoteric Testing Market size is estimated to reach USD 21 billion by 2028, according to a latest forecast report by Graphical Research.

Rising awareness about the benefits of early disease diagnosis will boost the industry size. Early disease diagnosis helps patients in the commencement of treatment for the diagnosed disease as well as assists in better recovery. Esoteric testing allows for improved assessment of the disease and medication plan.

The growing incidence of rare and infectious diseases in the region is likely to influence the industry trends. Emerging diseases include SARS, HIV infections, Lyme disease, hantavirus, West Nile virus, and the Zika virus. Studies reveal that rapid urbanization, climate change, and changing land-use patterns will increase the risk of diseases in the coming decades. It will fuel the demand for advanced disease diagnosis and testing methods, such as esoteric testing.

The endocrinology test type segment accounted for USD 2.2 billion revenue in 2021, attributed to the increasing occurrence of hormonal disorders due to sedentary lifestyle adoption and consumption of unhealthy food is accelerating endocrinology test demand. Climate change has significantly altered the range of global pathogens, allowing infections, particularly vector-borne infections, to expand into new locations.

According to the American Thyroid Association estimates, over 12% of the U.S. population is expected to develop a thyroid condition in their lifetime. An endocrine test can help diagnose a variety of hormonal diseases and specialties, including neuroendocrine & carcinoid tumors, pituitary thyroid adrenal bone, and parathyroid, among others. With a growing geriatric population in the region, which is prone to various endocrine dysfunction.

The chemiluminescence technology segment held more than USD 2.7 billion revenue in 2021, owing to its high reliability and receptivity.

In comparison with other technologies, chemiluminescence can assay a large number of test samples in shorter time duration. Other key advantages of the technology reside in the wide dynamic range, rapid acquisition of the analytical signal, high signal intensity, and stability of reagents and their conjugates.

Browse detailed statistical insights from the report, “North America Esoteric Testing Market Forecast 2028 By Test Type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics), By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, RT-PCR), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

Canada esoteric testing industry is set to register commendable growth over the coming years. With growing emphasis on the procurement of advanced diagnostic and testing methods in academic and commercial laboratories, the nation is actively developing esoteric testing tools.

Antimicrobial resistance, avian influenza, brucellosis, chikungunya, and cholera are listed among the most common infectious diseases in the region. To battle these ailments, Canada is focusing on enhancing its strong healthcare infrastructure and actively investing in research and development for new drug development.

The North American market for esoteric testing research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:

North America Market, By Test Type

  • Endocrinology
  • Infectious Disease & Immunology
  • Oncology
  • Toxicology
  • Neurology
  • Genomics
  • Others

North America Market, By Technology

  • Mass Spectrometry
  • Flow Cytometry
  • Radioimmunoassay
  • Chemiluminescence
  • RT-PCR
  • Others

The above information has been provided for the following countries:

  • North America
    • U.S.
    • Canada